ARCHIVES

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Evansvile CCOP Withdrawn, Cites Budget Cut, DR

September 9, 1983

Tobacco Linked To 63 Percent Of Cancer Deaths In Black Men

July 29, 2005

House Committee Alleges Irregularities In Tamoxifen Trial Informed Consent Forms

October 30, 1992

NCI Viewed As NIH’s ‘Administrative Reserve,” Broder Tells Directors

July 12, 1991

IOM Omics Committee Offers Blueprint to Prevent Other Duke-Style Disasters

March 23, 2012

NCI Puts $36 Million In Stimulus Funds Towards Early Clinical Trials

September 4, 2009